Wall Street Zen downgraded shares of Plexus (NASDAQ:PLXS – Free Report) from a buy rating to a hold rating in a research report report published on Sunday morning.
A number of other brokerages have also issued reports on PLXS. Stifel Nicolaus raised their price objective on shares of Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a report on Friday, January 30th. Williams Trading set a $195.00 price target on shares of Plexus in a research report on Wednesday, January 28th. Benchmark lifted their target price on Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Weiss Ratings lowered Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, February 20th. Finally, Needham & Company LLC increased their price target on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, January 30th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $189.20.
View Our Latest Analysis on PLXS
Plexus Stock Up 1.0%
Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.Plexus’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, sell-side analysts anticipate that Plexus will post 5.9 earnings per share for the current fiscal year.
Insider Buying and Selling at Plexus
In related news, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the business’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $203.06, for a total value of $873,767.18. Following the transaction, the chief accounting officer owned 20,099 shares in the company, valued at $4,081,302.94. The trade was a 17.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Oliver K. Mihm sold 9,541 shares of the stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $201.40, for a total value of $1,921,557.40. Following the sale, the chief operating officer owned 12,809 shares of the company’s stock, valued at approximately $2,579,732.60. The trade was a 42.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 47,995 shares of company stock valued at $9,718,476 over the last three months. 1.78% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Plexus
Large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC increased its holdings in Plexus by 103.1% in the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock worth $1,074,000 after purchasing an additional 4,255 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Plexus by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock worth $2,046,000 after buying an additional 705 shares in the last quarter. United Services Automobile Association acquired a new stake in shares of Plexus during the 1st quarter worth approximately $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock valued at $10,197,000 after acquiring an additional 9,078 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its stake in shares of Plexus by 6.0% in the 2nd quarter. Envestnet Asset Management Inc. now owns 60,413 shares of the technology company’s stock valued at $8,174,000 after acquiring an additional 3,398 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Read More
- Five stocks we like better than Plexus
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
